Get the Stockscreener App
1.25
2.34%
-0.03
Revelation Biosciences Inc stock is traded at $1.25, with a volume of 48,893.
It is down -2.34% in the last 24 hours and down -12.59% over the past month.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
See More
Previous Close:
$1.28
Open:
$1.26
24h Volume:
48,893
Relative Volume:
0.13
Market Cap:
$2.92M
Revenue:
-
Net Income/Loss:
$-15.52M
P/E Ratio:
-0.0673
EPS:
-18.58
Net Cash Flow:
$-16.61M
1W Performance:
+3.31%
1M Performance:
-12.59%
6M Performance:
-57.88%
1Y Performance:
-90.86%
1-Day Range:
$1.25
$1.29
1-Week Range:
$1.1928
$1.38
52-Week Range:
$0.702
$20.16
Revelation Biosciences Inc Stock (REVB) Company Profile
Name
Revelation Biosciences Inc
Sector
Industry
Phone
650-800-3717
Address
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Compare REVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
REVB
Revelation Biosciences Inc
|
1.25 | 2.99M | 0 | -15.52M | -16.61M | -18.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
419.89 | 106.97B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
654.04 | 68.62B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.56 | 63.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
820.36 | 50.61B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
194.22 | 35.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Revelation Biosciences Inc Stock (REVB) Latest News
What to do if you’re stuck in Revelation Biosciences Inc. Equity Warrant2025 Technical Patterns & Free Community Consensus Stock Picks - newser.com
Pattern recognition hints at Revelation Biosciences Inc. Equity Warrant upsideJuly 2025 Sentiment & Fast Gain Swing Alerts - newser.com
Tick level data insight on Revelation Biosciences Inc. Equity Warrant volatilityQuarterly Portfolio Report & Smart Investment Allocation Insights - newser.com
Why Revelation Biosciences Inc. Equity Warrant stock could rally in 20252025 Bull vs Bear & Real-Time Volume Analysis - newser.com
Using data filters to optimize entry into Revelation Biosciences Inc.July 2025 Sector Moves & Stock Portfolio Risk Management - newser.com
Chart based analysis of Revelation Biosciences Inc. Equity Warrant trendsBond Market & Growth-Oriented Investment Plans - newser.com
Will Revelation Biosciences Inc. Equity Warrant stock benefit from AI adoption2025 Price Action Summary & Safe Entry Zone Tips - newser.com
Does Revelation Biosciences Inc. Equity Warrant stock trade at a discount to peersJuly 2025 Sector Moves & Reliable Breakout Forecasts - newser.com
Using Bollinger Bands to evaluate Revelation Biosciences Inc. Equity WarrantWeekly Market Report & Low Risk Entry Point Guides - newser.com
Is Revelation Biosciences Inc Equity Warrant a good long term investmentPrice Volatility Patterns & AI-Driven Stock Forecast Models - earlytimes.in
How institutional buying supports Revelation Biosciences Inc. Equity Warrant stockMarket Growth Review & Low Volatility Stock Recommendations - newser.com
How Revelation Biosciences Inc. Equity Warrant stock reacts to oil pricesJuly 2025 Catalysts & Advanced Technical Signal Analysis - newser.com
Is Revelation Biosciences Inc. stock attractive for growth ETFsWeekly Stock Recap & Precise Entry and Exit Recommendations - newser.com
Published on: 2025-10-30 05:44:04 - newser.com
Volume spikes in Revelation Biosciences Inc. stock – what they meanEarnings Performance Report & Technical Pattern Alert System - newser.com
Is Revelation Biosciences Inc. Equity Warrant building a consolidation basePortfolio Performance Summary & Capital Protection Trading Alerts - newser.com
Will Revelation Biosciences Inc. stock benefit from automationJuly 2025 Opening Moves & High Conviction Buy Zone Alerts - newser.com
How high can Revelation Biosciences Inc. Equity Warrant stock goJuly 2025 Pullbacks & AI Optimized Trading Strategy Guides - newser.com
Can Revelation Biosciences Inc. Equity Warrant stock sustain institutional interestMarket Activity Recap & Community Verified Watchlist Alerts - newser.com
Analyzing recovery setups for Revelation Biosciences Inc. Equity Warrant investors2025 Growth vs Value & AI Based Buy/Sell Signal Reports - newser.com
Analyzing Revelation Biosciences Inc. with multi timeframe chartsMarket Volume Summary & Real-Time Volume Surge Alerts - newser.com
Revelation Biosciences Reschedules Stockholder Meeting - TipRanks
Revelation Biosciences Inc Cancels Special Meeting and Sets New Date - TradingView
Revelation Biosciences announces cancellation of Special Meeting - TipRanks
Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date - The Batesville Daily Guard
Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date | REVB Stock News - Stock Titan
What catalysts could drive Revelation Biosciences Inc. Equity Warrant stock higherQuarterly Earnings Report & Weekly Watchlist for Hot Stocks - newser.com
Published on: 2025-10-29 02:16:43 - newser.com
Pharma News: Why Revelation Biosciences Inc. Equity Warrant stock could rally in 2025Weekly Gains Report & AI Enhanced Trading Alerts - Fundação Cultural do Pará
Applying Elliott Wave Theory to Revelation Biosciences Inc.Weekly Trend Recap & High Conviction Buy Zone Alerts - newser.com
Best data tools to analyze Revelation Biosciences Inc. Equity Warrant stockJuly 2025 Spike Watch & Technical Pattern Based Buy Signals - newser.com
Revelation Biosciences Inc Stock (REVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
0.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):